25 XP   0   0   10

Consun Pharmaceutical Group
Buy, Hold or Sell?

Let's analyse Consun Pharmaceutical Group together

PenkeI guess you are interested in Consun Pharmaceutical Group. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Consun Pharmaceutical Group. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Consun Pharmaceutical Group

I send you an email if I find something interesting about Consun Pharmaceutical Group.

Quick analysis of Consun Pharmaceutical Group (30 sec.)










What can you expect buying and holding a share of Consun Pharmaceutical Group? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.09
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$4.19
Expected worth in 1 year
HK$7.24
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
HK$3.73
Return On Investment
65.2%

For what price can you sell your share?

Current Price per Share
HK$5.72
Expected price per share
HK$5 - HK$5.99
How sure are you?
50%

1. Valuation of Consun Pharmaceutical Group (5 min.)




Live pricePrice per Share (EOD)

HK$5.72

Intrinsic Value Per Share

HK$7.96 - HK$22.84

Total Value Per Share

HK$12.15 - HK$27.03

2. Growth of Consun Pharmaceutical Group (5 min.)




Is Consun Pharmaceutical Group growing?

Current yearPrevious yearGrowGrow %
How rich?$433.6m$360.9m$72.7m16.8%

How much money is Consun Pharmaceutical Group making?

Current yearPrevious yearGrowGrow %
Making money$94.1m$81.3m$12.7m13.6%
Net Profit Margin29.2%28.9%--

How much money comes from the company's main activities?

3. Financial Health of Consun Pharmaceutical Group (5 min.)




What can you expect buying and holding a share of Consun Pharmaceutical Group? (5 min.)

Welcome investor! Consun Pharmaceutical Group's management wants to use your money to grow the business. In return you get a share of Consun Pharmaceutical Group.

What can you expect buying and holding a share of Consun Pharmaceutical Group?

First you should know what it really means to hold a share of Consun Pharmaceutical Group. And how you can make/lose money.

Speculation

The Price per Share of Consun Pharmaceutical Group is HK$5.72. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Consun Pharmaceutical Group.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Consun Pharmaceutical Group, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$4.19. Based on the TTM, the Book Value Change Per Share is HK$0.76 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.17 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Consun Pharmaceutical Group.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.122.0%0.122.0%0.101.7%0.081.3%0.061.0%
Usd Book Value Change Per Share0.101.7%0.101.7%0.010.3%0.040.7%0.050.9%
Usd Dividend Per Share0.020.4%0.020.4%0.030.6%0.020.4%0.020.4%
Usd Total Gains Per Share0.122.1%0.122.1%0.050.8%0.071.2%0.071.2%
Usd Price Per Share0.52-0.52-0.56-0.53-0.61-
Price to Earnings Ratio4.45-4.45-5.69-13.86-16.28-
Price-to-Total Gains Ratio4.34-4.34-11.78-17.54-6.18-
Price to Book Ratio0.97-0.97-1.28-1.25-2.02-
Price-to-Total Gains Ratio4.34-4.34-11.78-17.54-6.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.730444
Number of shares1369
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.100.04
Usd Total Gains Per Share0.120.07
Gains per Quarter (1369 shares)162.9691.24
Gains per Year (1369 shares)651.83364.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1119533642136229355
223810661294271459720
3356159919464076881085
4475213225985429181450
55942665325067811471815
67133198390281313762180
78323731455494916062545
895142645206108418352910
9106947975858122020653275
10118853306510135522943640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.02.084.6%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%10.03.00.076.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%12.01.00.092.3%

Fundamentals of Consun Pharmaceutical Group

About Consun Pharmaceutical Group

Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yuan, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; and Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, tonics, and other medicines. Consun Pharmaceutical Group Limited was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-16 00:37:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Consun Pharmaceutical Group.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Consun Pharmaceutical Group earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Consun Pharmaceutical Group to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 29.2% means that $0.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Consun Pharmaceutical Group:

  • The MRQ is 29.2%. The company is making a huge profit. +2
  • The TTM is 29.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ29.2%TTM29.2%0.0%
TTM29.2%YOY28.9%+0.3%
TTM29.2%5Y23.3%+5.9%
5Y23.3%10Y25.1%-1.8%
1.1.2. Return on Assets

Shows how efficient Consun Pharmaceutical Group is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Consun Pharmaceutical Group to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.0% Return on Assets means that Consun Pharmaceutical Group generated $0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Consun Pharmaceutical Group:

  • The MRQ is 14.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 14.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.0%TTM14.0%0.0%
TTM14.0%YOY13.5%+0.4%
TTM14.0%5Y10.8%+3.1%
5Y10.8%10Y11.3%-0.4%
1.1.3. Return on Equity

Shows how efficient Consun Pharmaceutical Group is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Consun Pharmaceutical Group to the Drug Manufacturers - Specialty & Generic industry mean.
  • 21.7% Return on Equity means Consun Pharmaceutical Group generated $0.22 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Consun Pharmaceutical Group:

  • The MRQ is 21.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 21.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ21.7%TTM21.7%0.0%
TTM21.7%YOY22.5%-0.8%
TTM21.7%5Y18.5%+3.3%
5Y18.5%10Y17.5%+1.0%

1.2. Operating Efficiency of Consun Pharmaceutical Group.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Consun Pharmaceutical Group is operating .

  • Measures how much profit Consun Pharmaceutical Group makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Consun Pharmaceutical Group to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 30.6% means the company generated $0.31  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Consun Pharmaceutical Group:

  • The MRQ is 30.6%. The company is operating very efficient. +2
  • The TTM is 30.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.6%TTM30.6%0.0%
TTM30.6%YOY32.3%-1.7%
TTM30.6%5Y32.1%-1.5%
5Y32.1%10Y32.9%-0.8%
1.2.2. Operating Ratio

Measures how efficient Consun Pharmaceutical Group is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are $0.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Consun Pharmaceutical Group:

  • The MRQ is 0.939. The company is less efficient in keeping operating costs low.
  • The TTM is 0.939. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.939TTM0.9390.000
TTM0.939YOY0.934+0.005
TTM0.9395Y0.829+0.110
5Y0.82910Y0.746+0.083

1.3. Liquidity of Consun Pharmaceutical Group.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Consun Pharmaceutical Group is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.68 means the company has $2.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Consun Pharmaceutical Group:

  • The MRQ is 2.682. The company is able to pay all its short-term debts. +1
  • The TTM is 2.682. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.682TTM2.6820.000
TTM2.682YOY2.251+0.431
TTM2.6825Y2.237+0.445
5Y2.23710Y3.595-1.357
1.3.2. Quick Ratio

Measures if Consun Pharmaceutical Group is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Consun Pharmaceutical Group to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.88 means the company can pay off $2.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Consun Pharmaceutical Group:

  • The MRQ is 2.879. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.879. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.879TTM2.8790.000
TTM2.879YOY2.121+0.758
TTM2.8795Y2.127+0.752
5Y2.12710Y2.298-0.171

1.4. Solvency of Consun Pharmaceutical Group.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Consun Pharmaceutical Group assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Consun Pharmaceutical Group to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.36 means that Consun Pharmaceutical Group assets are financed with 35.7% credit (debt) and the remaining percentage (100% - 35.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Consun Pharmaceutical Group:

  • The MRQ is 0.357. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.357. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.357TTM0.3570.000
TTM0.357YOY0.400-0.043
TTM0.3575Y0.371-0.014
5Y0.37110Y0.295+0.076
1.4.2. Debt to Equity Ratio

Measures if Consun Pharmaceutical Group is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Consun Pharmaceutical Group to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 55.6% means that company has $0.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Consun Pharmaceutical Group:

  • The MRQ is 0.556. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.556. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.556TTM0.5560.000
TTM0.556YOY0.667-0.111
TTM0.5565Y0.644-0.088
5Y0.64410Y0.497+0.147

2. Market Valuation of Consun Pharmaceutical Group

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Consun Pharmaceutical Group generates.

  • Above 15 is considered overpriced but always compare Consun Pharmaceutical Group to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 4.45 means the investor is paying $4.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Consun Pharmaceutical Group:

  • The EOD is 6.285. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.450. Based on the earnings, the company is cheap. +2
  • The TTM is 4.450. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.285MRQ4.450+1.835
MRQ4.450TTM4.4500.000
TTM4.450YOY5.691-1.241
TTM4.4505Y13.861-9.411
5Y13.86110Y16.282-2.421
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Consun Pharmaceutical Group:

  • The EOD is 4.790. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.391. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.391. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.790MRQ3.391+1.398
MRQ3.391TTM3.3910.000
TTM3.391YOY5.354-1.963
TTM3.3915Y7.291-3.899
5Y7.29110Y15.992-8.701
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Consun Pharmaceutical Group is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Consun Pharmaceutical Group:

  • The EOD is 1.365. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.966. Based on the equity, the company is cheap. +2
  • The TTM is 0.966. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.365MRQ0.966+0.398
MRQ0.966TTM0.9660.000
TTM0.966YOY1.283-0.317
TTM0.9665Y1.252-0.285
5Y1.25210Y2.019-0.767
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Consun Pharmaceutical Group compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7620.7620%0.114+568%0.328+132%0.381+100%
Book Value Per Share--4.1924.1920%3.429+22%3.379+24%2.679+56%
Current Ratio--2.6822.6820%2.251+19%2.237+20%3.595-25%
Debt To Asset Ratio--0.3570.3570%0.400-11%0.371-4%0.295+21%
Debt To Equity Ratio--0.5560.5560%0.667-17%0.644-14%0.497+12%
Dividend Per Share--0.1700.1700%0.260-35%0.194-12%0.163+4%
Eps--0.9100.9100%0.773+18%0.603+51%0.456+100%
Free Cash Flow Per Share--1.1941.1940%0.822+45%0.807+48%0.531+125%
Free Cash Flow To Equity Per Share--0.7380.7380%0.603+22%0.487+52%0.412+79%
Gross Profit Margin--1.0001.0000%1.0000%-0.810+181%-0.493+149%
Intrinsic Value_10Y_max--22.837--------
Intrinsic Value_10Y_min--7.957--------
Intrinsic Value_1Y_max--1.304--------
Intrinsic Value_1Y_min--0.604--------
Intrinsic Value_3Y_max--4.667--------
Intrinsic Value_3Y_min--1.993--------
Intrinsic Value_5Y_max--8.936--------
Intrinsic Value_5Y_min--3.567--------
Market Cap4634401108.480+29%3281350435.2003281350435.2000%3626559200.000-10%3481190683.040-6%4205572866.776-22%
Net Profit Margin--0.2920.2920%0.289+1%0.233+25%0.251+16%
Operating Margin--0.3060.3060%0.323-5%0.321-5%0.329-7%
Operating Ratio--0.9390.9390%0.934+1%0.829+13%0.746+26%
Pb Ratio1.365+29%0.9660.9660%1.283-25%1.252-23%2.019-52%
Pe Ratio6.285+29%4.4504.4500%5.691-22%13.861-68%16.282-73%
Price Per Share5.720+29%4.0504.0500%4.400-8%4.138-2%4.741-15%
Price To Free Cash Flow Ratio4.790+29%3.3913.3910%5.354-37%7.291-53%15.992-79%
Price To Total Gains Ratio6.136+29%4.3454.3450%11.777-63%17.539-75%6.178-30%
Quick Ratio--2.8792.8790%2.121+36%2.127+35%2.298+25%
Return On Assets--0.1400.1400%0.135+3%0.108+29%0.113+24%
Return On Equity--0.2170.2170%0.225-4%0.185+18%0.175+24%
Total Gains Per Share--0.9320.9320%0.374+149%0.522+79%0.543+72%
Usd Book Value--433684663.474433684663.4740%360956546.594+20%360807349.117+20%296955641.029+46%
Usd Book Value Change Per Share--0.0970.0970%0.015+568%0.042+132%0.049+100%
Usd Book Value Per Share--0.5350.5350%0.438+22%0.431+24%0.342+56%
Usd Dividend Per Share--0.0220.0220%0.033-35%0.025-12%0.021+4%
Usd Eps--0.1160.1160%0.099+18%0.077+51%0.058+100%
Usd Free Cash Flow--123562262.301123562262.3010%86496892.982+43%85519194.464+44%58085597.877+113%
Usd Free Cash Flow Per Share--0.1530.1530%0.105+45%0.103+48%0.068+125%
Usd Free Cash Flow To Equity Per Share--0.0940.0940%0.077+22%0.062+52%0.053+79%
Usd Market Cap591813021.553+29%419028450.575419028450.5750%463111609.840-10%444548050.224-6%537051655.087-22%
Usd Price Per Share0.730+29%0.5170.5170%0.562-8%0.528-2%0.605-15%
Usd Profit--94166360.36794166360.3670%81379088.559+16%63899542.288+47%50117377.022+88%
Usd Revenue--322615414.739322615414.7390%281939107.944+14%267765871.544+20%203066357.753+59%
Usd Total Gains Per Share--0.1190.1190%0.048+149%0.067+79%0.069+72%
 EOD+4 -4MRQTTM+0 -0YOY+26 -95Y+28 -810Y+27 -9

3.2. Fundamental Score

Let's check the fundamental score of Consun Pharmaceutical Group based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.285
Price to Book Ratio (EOD)Between0-11.365
Net Profit Margin (MRQ)Greater than00.292
Operating Margin (MRQ)Greater than00.306
Quick Ratio (MRQ)Greater than12.879
Current Ratio (MRQ)Greater than12.682
Debt to Asset Ratio (MRQ)Less than10.357
Debt to Equity Ratio (MRQ)Less than10.556
Return on Equity (MRQ)Greater than0.150.217
Return on Assets (MRQ)Greater than0.050.140
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Consun Pharmaceutical Group based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.253
Ma 20Greater thanMa 505.635
Ma 50Greater thanMa 1005.622
Ma 100Greater thanMa 2005.251
OpenGreater thanClose5.640
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Minority Interest  366,908-29,280337,629-17,866319,762-316,4633,299-4,152-853



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,892,380
Total Liabilities1,747,241
Total Stockholder Equity3,145,139
 As reported
Total Liabilities 1,747,241
Total Stockholder Equity+ 3,145,139
Total Assets = 4,892,380

Assets

Total Assets4,892,380
Total Current Assets3,622,671
Long-term Assets1,269,709
Total Current Assets
Cash And Cash Equivalents 2,450,173
Short-term Investments 589,172
Net Receivables 259,562
Inventory 276,080
Total Current Assets  (as reported)3,622,671
Total Current Assets  (calculated)3,574,987
+/- 47,684
Long-term Assets
Property Plant Equipment 782,337
Intangible Assets 311,904
Other Assets 189,965
Long-term Assets  (as reported)1,269,709
Long-term Assets  (calculated)1,284,206
+/- 14,497

Liabilities & Shareholders' Equity

Total Current Liabilities1,350,488
Long-term Liabilities102,887
Total Stockholder Equity3,145,139
Total Current Liabilities
Short-term Debt 450,521
Short Long Term Debt 450,521
Accounts payable 59,891
Other Current Liabilities 270,236
Total Current Liabilities  (as reported)1,350,488
Total Current Liabilities  (calculated)1,231,169
+/- 119,319
Long-term Liabilities
Long term Debt Total 5,947
Capital Lease Obligations 9,655
Long-term Liabilities  (as reported)102,887
Long-term Liabilities  (calculated)15,602
+/- 87,285
Total Stockholder Equity
Common Stock63,450
Retained Earnings 3,079,606
Other Stockholders Equity 2,083
Total Stockholder Equity (as reported)3,145,139
Total Stockholder Equity (calculated)3,145,139
+/-0
Other
Capital Stock63,450
Cash And Equivalents2,450,173
Cash and Short Term Investments 3,039,345
Common Stock Shares Outstanding 806,973
Liabilities and Stockholders Equity 4,892,380
Net Invested Capital 3,595,660
Net Working Capital 2,272,183
Property Plant and Equipment Gross 1,093,184



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
432,213
497,021
646,007
1,456,945
1,662,941
1,917,891
2,759,055
3,572,017
3,897,038
3,708,086
3,950,253
4,362,738
4,892,380
4,892,3804,362,7383,950,2533,708,0863,897,0383,572,0172,759,0551,917,8911,662,9411,456,945646,007497,021432,213
   > Total Current Assets 
0
0
445,058
1,192,689
1,396,529
960,188
1,390,005
2,184,651
2,396,155
2,409,648
2,658,697
3,055,829
3,622,671
3,622,6713,055,8292,658,6972,409,6482,396,1552,184,6511,390,005960,1881,396,5291,192,689445,05800
       Cash And Cash Equivalents 
32,021
64,871
81,755
902,026
843,669
489,987
672,711
989,565
1,269,746
1,383,232
1,940,273
2,196,323
2,450,173
2,450,1732,196,3231,940,2731,383,2321,269,746989,565672,711489,987843,669902,02681,75564,87132,021
       Short-term Investments 
0
0
76,470
0
250,900
0
0
0
0
0
0
230,000
589,172
589,172230,000000000250,900076,47000
       Net Receivables 
198,407
223,497
253,467
232,493
243,678
363,703
566,421
986,070
884,271
792,245
458,426
222,590
259,562
259,562222,590458,426792,245884,271986,070566,421363,703243,678232,493253,467223,497198,407
       Other Current Assets 
6,348
7,223
10,924
9,204
4,800
12,728
9,899
9,015
31,828
23,487
32,624
16,904
0
016,90432,62423,48731,8289,0159,89912,7284,8009,20410,9247,2236,348
   > Long-term Assets 
0
0
0
0
0
0
1,369,050
1,387,366
1,500,883
1,298,438
1,291,556
1,306,909
1,269,709
1,269,7091,306,9091,291,5561,298,4381,500,8831,387,3661,369,050000000
       Property Plant Equipment 
127,212
150,902
171,497
232,270
229,914
223,773
392,882
400,797
561,785
788,117
721,452
782,224
782,337
782,337782,224721,452788,117561,785400,797392,882223,773229,914232,270171,497150,902127,212
       Goodwill 
0
0
0
0
0
0
320,647
320,647
320,647
0
0
0
0
0000320,647320,647320,647000000
       Long Term Investments 
0
0
0
2,600
2,600
639,259
2,600
2,600
0
0
0
0
0
000002,6002,600639,2592,6002,600000
       Intangible Assets 
22,736
22,234
0
0
0
0
489,629
460,215
430,800
396,071
499,494
341,664
311,904
311,904341,664499,494396,071430,800460,215489,629000022,23422,736
       Long-term Assets Other 
0
0
0
0
0
0
1,369,050
1,387,366
1,500,883
1,298,438
0
0
0
0001,298,4381,500,8831,387,3661,369,050000000
> Total Liabilities 
184,530
251,001
290,829
199,581
229,755
281,136
698,004
1,507,869
1,400,026
1,401,325
1,433,755
1,745,033
1,747,241
1,747,2411,745,0331,433,7551,401,3251,400,0261,507,869698,004281,136229,755199,581290,829251,001184,530
   > Total Current Liabilities 
174,401
235,299
260,347
150,115
178,247
229,350
546,731
970,233
999,153
1,296,294
1,331,863
1,357,407
1,350,488
1,350,4881,357,4071,331,8631,296,294999,153970,233546,731229,350178,247150,115260,347235,299174,401
       Short-term Debt 
0
0
0
0
0
0
0
193,621
147,202
553,567
549,414
599,302
450,521
450,521599,302549,414553,567147,202193,6210000000
       Short Long Term Debt 
0
0
0
0
0
0
0
193,621
147,202
553,567
549,414
599,302
450,521
450,521599,302549,414553,567147,202193,6210000000
       Accounts payable 
32,025
16,269
31,976
20,567
36,416
39,760
79,733
68,739
92,755
55,520
50,889
66,638
59,891
59,89166,63850,88955,52092,75568,73979,73339,76036,41620,56731,97616,26932,025
       Other Current Liabilities 
142,376
205,430
228,371
129,548
141,831
94,812
229,616
296,140
313,028
322,610
325,143
222,815
270,236
270,236222,815325,143322,610313,028296,140229,61694,812141,831129,548228,371205,430142,376
   > Long-term Liabilities 
0
0
0
0
0
0
151,273
537,636
400,873
105,031
101,892
94,550
102,887
102,88794,550101,892105,031400,873537,636151,273000000
       Long term Debt Total 
0
0
0
0
0
0
0
374,483
245,336
0
0
8,547
5,947
5,9478,54700245,336374,4830000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
4,323
684
0
0
0
0
00006844,3230000000
> Total Stockholder Equity
247,683
246,020
355,178
1,257,364
1,433,186
1,636,755
1,760,494
1,746,688
2,157,219
1,994,084
2,220,367
2,617,705
3,145,139
3,145,1392,617,7052,220,3671,994,0842,157,2191,746,6881,760,4941,636,7551,433,1861,257,364355,178246,020247,683
   Common Stock
80,770
80,770
1
78,250
78,250
78,074
76,237
68,652
68,782
68,033
64,424
64,800
63,450
63,45064,80064,42468,03368,78268,65276,23778,07478,25078,250180,77080,770
   Retained Earnings 
167,110
165,417
274,598
375,925
587,125
910,537
1,133,553
1,316,895
1,782,248
1,640,449
2,155,943
2,392,552
3,079,606
3,079,6062,392,5522,155,9431,640,4491,782,2481,316,8951,133,553910,537587,125375,925274,598165,417167,110
   Capital Surplus 
0
0
0
0
0
647,937
454,130
247,272
187,906
145,402
0
19,789
0
019,7890145,402187,906247,272454,130647,93700000
   Treasury Stock00000-88,642-88,642000000
   Other Stockholders Equity 
0
0
0
80,588
83,210
207
185,216
202,511
206,925
228,842
2,155,943
253,888
2,083
2,083253,8882,155,943228,842206,925202,511185,21620783,21080,588000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,339,650
Cost of Revenue-576,738
Gross Profit1,762,9121,762,912
 
Operating Income (+$)
Gross Profit1,762,912
Operating Expense-1,620,193
Operating Income757,326142,719
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,061,971
Selling And Marketing Expenses0
Operating Expense1,620,1931,061,971
 
Net Interest Income (+$)
Interest Income10,933
Interest Expense-43,136
Other Finance Cost-73,684
Net Interest Income41,481
 
Pretax Income (+$)
Operating Income757,326
Net Interest Income41,481
Other Non-Operating Income Expenses0
Income Before Tax (EBT)746,393757,326
EBIT - interestExpense = 672,272
682,907
726,043
Interest Expense43,136
Earnings Before Interest and Taxes (EBIT)715,408789,529
Earnings Before Interest and Taxes (EBITDA)833,681
 
After tax Income (+$)
Income Before Tax746,393
Tax Provision-62,696
Net Income From Continuing Ops683,697683,697
Net Income682,907
Net Income Applicable To Common Shares682,907
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses14,467
Total Other Income/Expenses Net0-41,481
 

Technical Analysis of Consun Pharmaceutical Group
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Consun Pharmaceutical Group. The general trend of Consun Pharmaceutical Group is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Consun Pharmaceutical Group's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Consun Pharmaceutical Group.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5.78 < 5.99 < 5.99.

The bearish price targets are: 5.35 > 5.1 > 5.

Tweet this
Consun Pharmaceutical Group Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Consun Pharmaceutical Group. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Consun Pharmaceutical Group Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Consun Pharmaceutical Group. The current macd is -0.01169336.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Consun Pharmaceutical Group price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Consun Pharmaceutical Group. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Consun Pharmaceutical Group price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Consun Pharmaceutical Group Daily Moving Average Convergence/Divergence (MACD) ChartConsun Pharmaceutical Group Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Consun Pharmaceutical Group. The current adx is 25.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Consun Pharmaceutical Group shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Consun Pharmaceutical Group Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Consun Pharmaceutical Group. The current sar is 5.35.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Consun Pharmaceutical Group Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Consun Pharmaceutical Group. The current rsi is 54.25. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Consun Pharmaceutical Group Daily Relative Strength Index (RSI) ChartConsun Pharmaceutical Group Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Consun Pharmaceutical Group. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Consun Pharmaceutical Group price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Consun Pharmaceutical Group Daily Stochastic Oscillator ChartConsun Pharmaceutical Group Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Consun Pharmaceutical Group. The current cci is 59.03.

Consun Pharmaceutical Group Daily Commodity Channel Index (CCI) ChartConsun Pharmaceutical Group Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Consun Pharmaceutical Group. The current cmo is 14.12.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Consun Pharmaceutical Group Daily Chande Momentum Oscillator (CMO) ChartConsun Pharmaceutical Group Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Consun Pharmaceutical Group. The current willr is -13.95348837.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Consun Pharmaceutical Group Daily Williams %R ChartConsun Pharmaceutical Group Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Consun Pharmaceutical Group.

Consun Pharmaceutical Group Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Consun Pharmaceutical Group. The current atr is 0.15039475.

Consun Pharmaceutical Group Daily Average True Range (ATR) ChartConsun Pharmaceutical Group Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Consun Pharmaceutical Group. The current obv is 44,127,125.

Consun Pharmaceutical Group Daily On-Balance Volume (OBV) ChartConsun Pharmaceutical Group Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Consun Pharmaceutical Group. The current mfi is 64.98.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Consun Pharmaceutical Group Daily Money Flow Index (MFI) ChartConsun Pharmaceutical Group Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Consun Pharmaceutical Group.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Consun Pharmaceutical Group Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Consun Pharmaceutical Group based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.253
Ma 20Greater thanMa 505.635
Ma 50Greater thanMa 1005.622
Ma 100Greater thanMa 2005.251
OpenGreater thanClose5.640
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Consun Pharmaceutical Group with someone you think should read this too:
  • Are you bullish or bearish on Consun Pharmaceutical Group? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Consun Pharmaceutical Group? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Consun Pharmaceutical Group

I send you an email if I find something interesting about Consun Pharmaceutical Group.


Comments

How you think about this?

Leave a comment

Stay informed about Consun Pharmaceutical Group.

Receive notifications about Consun Pharmaceutical Group in your mailbox!